Novo real-world studies link Vegobi® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with AASLD® (AASLD) 2026 -. Company announcement - FT.com.
Novo real-world studies link Vegobi® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with AASLD® (AASLD) 2026 -. Company announcement - FT.com.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in